Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;40(2):373-9.
doi: 10.1007/s00268-015-3254-7.

Survival and Local Recurrence After Video-Assisted Thoracoscopic Lung Metastasectomy

Survival and Local Recurrence After Video-Assisted Thoracoscopic Lung Metastasectomy

Etienne Abdelnour-Berchtold et al. World J Surg. 2016 Feb.

Abstract

Background: Pulmonary metastasectomy is increasingly performed in selected patients by video-assisted thoracic surgery (VATS) on the base of thin-slice high-resolution CT-Scan (HRCT). This study determines the overall survival and ipsilateral recurrence rate and of patients undergoing after VATS lung metastasectomy.

Patients and method: Retrospective single institution study of all patients who underwent VATS pulmonary metastasectomy on the base of HRCT with curative intent between 2005 and 2014.

Results: Seventy-seven patients (41 males, 36 females) underwent VATS pulmonary metastasectomy for solitary (n = 63) or multiple (n = 14) lung metastases in the context of colorectal carcinoma (n = 26), sarcoma (n = 17), melanoma (n = 16), or other primaries (n = 18). Nine patients had bilateral lung metastases and underwent synchronous (n = 4) or sequential (n = 5) VATS resections. Preoperative CT-guided hook wire localization of the lesions was performed in 65 patients (84 %). The postoperative mortality and morbidity rates were 0 and 5.2 %, respectively. During a mean follow-up time of 24 months (range 1–120 months), tumor progression occurred in 46 patients. Twenty-three patients (30 %) had pulmonary recurrence only, of them, eight patients (10 %) in the operated lungs. Seven of eight patients with recurrence in the operated lungs underwent a second metastasectomy by VATS (n = 5) or thoracotomy (n = 2). The overall 5-year survival rate was 54 % and without difference between patients without tumor recurrence and those with pulmonary recurrence treated by re-metastasectomy.

Conclusion: Ipsilateral recurrence remains low after VATS pulmonary metastasectomy guided by preoperative HRCT and can be efficiently treated by re-metastasectomy.

PubMed Disclaimer

References

    1. Crit Rev Oncol Hematol. 2015 Jul;95(1):105-13 - PubMed
    1. J Thorac Cardiovasc Surg. 1997 Jan;113(1):37-49 - PubMed
    1. J Thorac Oncol. 2010 Jun;5(6 Suppl 2):S140-4 - PubMed
    1. Ann Thorac Surg. 1996 Jul;62(1):213-6; discussion 216-7 - PubMed
    1. Surg Endosc. 2013 Jun;27(6):1938-44 - PubMed

MeSH terms

LinkOut - more resources